[Clinical and epidemiological changes of candidemia among adult patients from 2000 to 2013]

Rev Chilena Infectol. 2017 Feb;34(1):19-26. doi: 10.4067/S0716-10182017000100003.
[Article in Spanish]

Abstract

Background: Invasive Candida spp. infections have been described more frequently.

Aim: To characterize the epidemiological data of candidemia in recent years.

Methods: A retrospective study of adult patients in a University Hospital in Santiago, Chile, with 1 or more documented episodes of candidemia, from January 2000 to December 2013.

Results: One hundred and twenty episodes of candidemia were identified in 120 patients, annual incidence of 0.4 cases per 1000 discharges, 53.3% were male patients, 58.3% > 60 years, 77,5% had at least one co-morbidity. Candida albicans was the species most frequently identified 55%, followed by C. glabrata 18.3%, C. tropicalis 11.7% and C. parapsilosis 9.2%. Comparing 2000-2006 vs 2007-2013, increased the frequency of C. parapsilosis among non-albicans and echinocandins prescription. Patients with C. albicans showed higher APACHE-II, more requirement for invasive mechanical ventilation, greater association with CVC, and shorter incubation time compared with non-albicans species. The 30-day mortality was 31.7%.

Conclusions: During this 14-years period we observed that C. albicans was the predominant specie and more recently a change among C. non-albicans increasing C. parapsilosis and decreasing C. glabrata 30-days and attributable mortality decreased together with more echinocandins prescription.

MeSH terms

  • Adolescent
  • Adult
  • Antifungal Agents / pharmacology*
  • Candida / classification*
  • Candida / drug effects
  • Candidemia / epidemiology*
  • Candidemia / microbiology
  • Child
  • Child, Preschool
  • Chile / epidemiology
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology
  • Female
  • Humans
  • Incidence
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Sex Distribution
  • Young Adult

Substances

  • Antifungal Agents